16May/14

FDA Rejects Novel Novartis Drug For Acute Heart Failure – Forbes

FDA Rejects Novel Novartis Drug For Acute Heart Failure
Forbes
Novartis said it was “continuing to expand the data supporting the efficacy of RLX030 in acute heart failure with an extensive global clinical program, including the RELAX-AHF-2 trial which will enroll over 6,300 patients.” Move up http://i.forbesimg
US regulator rejects Novartis heart failure drugReuters
FDA Says No to Serelaxin for Heart FailureMedPage Today
Regulator Rejects Novartis Heart Failure DrugFox Business
MarketWatch
all 33 news articles »
16May/14

Blood Donation Poster Charges Phones & Asks – PSFK

Blood Donation Poster Charges Phones & Asks
PSFK
The goal of the Blood Charger poster campaign is to draw attention to the importance of supporting the foundation’s cause, especially before the World Cup. Dr. Alfredo Mendrone Junior, technical-scientific director of the blood donation foundation
Blood donation poster demonstrates sharing by acting as free phone chargersInside Mobile Apps
A Blood Donation Poster That Helps Save Lives And Charges Your PhoneGizmodo Australia

all 3 news articles »

16May/14

Advanced chronic kidney disease increased mortality in TAVR – Healio


YottaFire

Advanced chronic kidney disease increased mortality in TAVR
Healio
Stage 4 and 5 chronic kidney disease significantly predicted mortality in a cohort of patients who underwent transcatheter aortic valve replacement, according to a study published in the European Heart Journal. For the study, researchers aimed to
Chronic Kidney Disease Can Be Tackled By Walking More!YottaFire
Chronic Kidney Disease Risks’ Reduced By WalkingNews on Wellness
Walking benefits kidney disease patientsIrish Health
WebMD –Headlines & Global News –Medical News Today
all 28 news articles »